Literature DB >> 15351238

Localization of vascular endothelial growth factor during the early reparative phase of the rats' vessels deprivation-induced osteonecrosis of the femoral heads.

Z Vadasz1, I Misselevich, D Norman, E Peled, J H Boss.   

Abstract

The expedited revascularization of the rats' avascular, necrotic femoral heads suggests the operation of angiogenic factor(s). The blood circulation of the epiphysis was interrupted by cutting the cervical periosteum and the ligamentum teres of rats' femoral heads. Three days postoperatively, the marrow was necrotic. Seven days postoperatively, the subchondral bony plate and trabecular bone were necrotic as well. The joint capsule was distended by myriad, so-called synovial fibroblasts, all of which were virtually immunoreactive with an antibody to vascular endothelial growth factor. The expression of this factor in the synovial membrane of non-operated rats was limited to preexisting blood vessels. Revascularization of necrotic, avascular femoral heads makes up the essential step in the chain of events terminating in the repair processes, that is, resorption of the necrotic debris and its substitution by newly formed bony and hematopoietic-fatty tissues. Synthesis and release of excessive amounts of vascular endothelial growth factor by these fibroblasts explain the lively angiogenesis in the necrotic intertrabecular spaces of the femoral heads.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351238     DOI: 10.1016/j.yexmp.2004.06.002

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  13 in total

1.  3D-printed porous titanium changed femoral head repair growth patterns: osteogenesis and vascularisation in porous titanium.

Authors:  Wei Zhu; Yan Zhao; Qi Ma; Yingjie Wang; Zhihong Wu; Xisheng Weng
Journal:  J Mater Sci Mater Med       Date:  2017-03-01       Impact factor: 3.896

Review 2.  Experimental animal models of osteonecrosis.

Authors:  Meng Fan; Jiang Peng; Ling Qin; Shibi Lu
Journal:  Rheumatol Int       Date:  2011-02-22       Impact factor: 2.631

3.  Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH).

Authors:  Ozgur Basal; Tolga Atay; İbrahim Metin Ciris; Yakup Barbaros Baykal
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

4.  Osteonecrosis of the femoral head: An update in year 2012.

Authors:  Anjan P Kaushik; Anusuya Das; Quanjun Cui
Journal:  World J Orthop       Date:  2012-05-18

5.  Does dynamic immobilization reduce chondrocyte apoptosis and disturbance to the femoral head perfusion?

Authors:  Lian-Yong Li; Li-Jun Zhang; Jing-Yu Jia; Qun Zhao; En-Bo Wang; Qi-Wei Li
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

Review 6.  Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review.

Authors:  Katharine Shim; Mary J MacKenzie; Eric Winquist
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 7.  Avascular Necrosis of the Femoral Head: Are Any Genes Involved?

Authors:  Farzaneh Pouya; Mohammad Amin Kerachian
Journal:  Arch Bone Jt Surg       Date:  2015-07

8.  Therapeutic Study of Thermosensitive Hydrogel Loaded with Super-Activated Platelet Lysate Combined with Core Decompression Technology for the Treatment of Femoral Head Necrosis.

Authors:  Zhipeng Huang; Zhe Zhao; Jun Lang; Wantao Wang; Yinsheng Fu; Wenbo Wang
Journal:  Stem Cells Int       Date:  2021-06-25       Impact factor: 5.443

9.  An animal model of femoral head osteonecrosis induced by a single injection of absolute alcohol: an experimental study.

Authors:  Zhen-Hong Zhu; You-Shui Gao; Shi-Hua Luo; Bing-Fang Zeng; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2011-04

Review 10.  Vasculature deprivation--induced osteonecrosis of the rat femoral head as a model for therapeutic trials.

Authors:  Jacob Bejar; Eli Peled; Jochanan H Boss
Journal:  Theor Biol Med Model       Date:  2005-07-05       Impact factor: 2.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.